Short Interest Change: Stryker Corporation (NYSE:SYK) Just Reported Decreased Shorts

November 17, 2016 - By Dolores Ford   ·   0 Comments

Short Interest Change: Stryker Corporation (NYSE:SYK) Just Reported Decreased Shorts

The stock of Stryker Corporation (NYSE:SYK) registered a decrease of 0.89% in short interest. SYK’s total short interest was 5.15 million shares in November as published by FINRA. Its down 0.89% from 5.20M shares, reported previously. With 1.42 million shares average volume, it will take short sellers 4 days to cover their SYK’s short positions. The short interest to Stryker Corporation’s float is 1.57%. The stock decreased 0.32% or $0.35 during the last trading session, hitting $109.39. Stryker Corporation (NYSE:SYK) has declined 0.37% since April 15, 2016 and is downtrending. It has underperformed by 5.00% the S&P500.

Stryker Corporation is a medical technology company. The company has a market cap of $42.14 billion. The Firm operates through three divisions: Orthopaedics, MedSurg, and Neurotechnology and Spine. It has a 24.94 P/E ratio. The Company’s Orthopaedics segment products consist of implants used in hip and knee joint replacements and trauma and surgeries.

Insitutional Activity: The institutional sentiment increased to 0.93 in Q2 2016. Its up 0.14, from 0.79 in 2016Q1. The ratio improved, as 41 funds sold all Stryker Corporation shares owned while 325 reduced positions. 61 funds bought stakes while 280 increased positions. They now own 279.01 million shares or 2.26% less from 285.46 million shares in 2016Q1.
Advisory Serv Networks Limited Liability Company accumulated 2,377 shares or 0.06% of the stock. M&R Capital Mgmt reported 19,033 shares or 0.25% of all its holdings. Virginia Retirement Et Al has 32,600 shares for 0.06% of their US portfolio. Moreover, Burns J W & Com New York has 1.26% invested in Stryker Corporation (NYSE:SYK) for 34,651 shares. Invesco holds 0.11% or 2.50M shares in its portfolio. Zurcher Kantonalbank (Zurich Cantonalbank) holds 0.09% of its portfolio in Stryker Corporation (NYSE:SYK) for 58,994 shares. Dnb Asset Mngmt As accumulated 0% or 96,795 shares. Los Angeles & Equity Rech last reported 0.11% of its portfolio in the stock. Moreover, Bb&T has 0.1% invested in Stryker Corporation (NYSE:SYK) for 39,509 shares. Diam accumulated 0.08% or 45,387 shares. Donaldson Mngmt Limited Liability Corporation accumulated 3,016 shares or 0.05% of the stock. Comerica Natl Bank holds 0.15% of its portfolio in Stryker Corporation (NYSE:SYK) for 149,662 shares. Dumont & Blake Invest Limited Liability last reported 12,985 shares in the company. Covington Cap Mgmt reported 117,932 shares or 1.31% of all its holdings. Daiwa Gp accumulated 48,300 shares or 0.03% of the stock.

Insider Transactions: Since May 19, 2016, the stock had 2 insider purchases, and 64 insider sales for $86.96 million net activity. Another trade for 12,000 shares valued at $1.33M was made by STRYKER RONDA E on Monday, May 23. On Monday, June 6 Datar Srikant sold $747,754 worth of the stock or 6,565 shares. Shares for $5,308 were bought by Doliveux Roch. $1.11 million worth of Stryker Corporation (NYSE:SYK) shares were sold by COX HOWARD E JR. Owen Katherine Ann also sold $1.28M worth of Stryker Corporation (NYSE:SYK) shares. The insider Becker Yin C sold 12,000 shares worth $1.37M. The insider Lobo Kevin sold 26,306 shares worth $3.04 million.

Stryker Corporation (NYSE:SYK) Ratings Coverage

Out of 19 analysts covering Stryker Corporation (NYSE:SYK), 11 rate it a “Buy”, 2 “Sell”, while 6 “Hold”. This means 58% are positive. Stryker Corporation has been the topic of 25 analyst reports since July 27, 2015 according to StockzIntelligence Inc. The rating was maintained by Stifel Nicolaus on Wednesday, August 12 with “Buy”. The stock has “Hold” rating given by Needham on Monday, September 28. Brean Capital upgraded the stock to “Buy” rating in Wednesday, January 27 report. As per Thursday, November 12, the company rating was initiated by Citigroup. The firm has “Buy” rating given on Wednesday, August 5 by Argus Research. The rating was initiated by Barclays Capital with “Underweight” on Monday, April 11. RBC Capital Markets maintained Stryker Corporation (NYSE:SYK) rating on Friday, July 24. RBC Capital Markets has “Outperform” rating and $108 price target. The firm earned “Buy” rating on Wednesday, April 27 by Argus Research. The stock of Stryker Corporation (NYSE:SYK) earned “Neutral” rating by UBS on Tuesday, September 22. Credit Suisse reinitiated Stryker Corporation (NYSE:SYK) on Monday, August 10 with “Outperform” rating.

SYK Company Profile

Stryker Corporation (Stryker), incorporated on February 20, 1946, is a medical technology company. The Firm operates through three divisions: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Firm offers its products to doctors, hospitals and other healthcare facilities. The Company’s products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment, and neurosurgical, neurovascular and spinal devices, as well as other medical device products used in a range of medical specialties. The Company’s products are sold in approximately 100 countries through the Company-owned sales subsidiaries and branches, as well as third-party dealers and distributors. The Firm offers a 1588 advanced imaging modalities (AIM) platform, which is designed for optimum visualization across surgical specialties.

Another recent and important Stryker Corporation (NYSE:SYK) news was published by Businesswire.com which published an article titled: “Study To Be Presented at NASS 2016 Evaluating Bone In-Growth for Stryker’s 3D …” on October 28, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Dolores Ford


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>